Structural Biology in Cancer Research

The main aim of integrating Structural Biology data into cancer research is to style and find out novel and effective drugs to cure the disease. Structural biology combined with molecular modelling mainly aims at drug designing. Consequently, variety of Structural Biologists are conducting cancer research, to speed-up the method of understanding the mechanism of biomolecules so as to enhance the newer cancer therapies.

Major a part of research is being administered within the area of cancer. The most aim is to style and find out novel and effective drugs to cure the disease. Structural Biology combined with molecular modelling mainly aims at drug designing. Subsequently, numerous team leaders in Structural biology perform cancer research to accelerate the exploitation of molecular understanding of biomolecules within the advancement of novel cancer therapies.

  • Cancer systems biology
  • Tumorigenesis
  • Cancer heterogeneity
  • Epidemiology
  • Statistical and mechanistic modelling of signaling networks

    Related Conference of Structural Biology in Cancer Research

    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Aix-en-Provence, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    A Coruna, Spain

    Structural Biology in Cancer Research Conference Speakers